Abstract:Objective To determine the expression of miR-486-3p in psoriatic lesions and healthy human skin and to estimate its effect on keratin 17 (K17) expression in HaCaT human keratinocytes.Methods Bioinformatics was used to predict microRNAs that may affect the expression of K17.Tissue samples were obtained from the lesions of 10 patients with psoriasis and normal skin of 10 healthy human controls.RNA was extracted from these tissue samples and reversely transcribed into cDNA with the addition of a Poly (A) tail.Then,real time quantitative PCR was performed to measure the expression of miR-486-3p.Cultured keratinocytes were transfected with miR-486-3p mimics or negative control,and Western blot was performed to determine K17 expression at 48 hours after the transfection.To evaluate the inhibitory effect of miR-486-3p on K17 expression,cultured 293T cells were transfected with the plasmid containing K17 3' untranslated region (UTR) seed sequence,three plasmids containing the complete deletion,interval mutation or double repeats of the seed sequence,or negative control plasmid.At 24 hours after the transfection,a dualluciferase reporter (DLR) assay was performed to quantify the expression of K17.Results Real time PCR showed that the expression level of miR-486-3p was significantly lower in psoriatic lesions than in the normal skin (0.211 ± 0.120vs.0.555 ± 0.425,t =2.62,v =9,P ＜ 0.05).The HaCaT cells transfected with the mimics of miR-486-3p exhibited decreased expression of K17 compared with those transfected with the negative control.DLR assay revealed that the expression level (fluorescence intensity) of K17 in the negative control group was significantly higher than that in the 293T cells transfected with the seed sequence and those with the double repeats of the seed sequence (100.00％ vs.65.31％ ± 6.32％ and 54.18％ ± 10.01％ respectively,both P ＜ 0.05),but did not differ from that in the 293T cells transfected with the complete deletion and interval mutation of the seed sequence (100.00％ vs.114.77％ ± 16.14％ and 110.21％ ± 12.99％ respectively,both P ＞ 0.05).Conclusions The expression of miR-486-3p,which may inhibit K17 expression by binding to the seed sequence of K17 3'UTR,is lower in psoriatic lesions than in normal skin.The decreased expression and inhibitory effect of miR-486-3p may be implicated in the initiation and progression of psoriasis.

Expressions of Mir-203 and Its Downstream Target Genes P63 and Survivin in Psoriatic Lesions

Expression of Mir-486-3p in Psoriatic Lesions and Its Effect on Keratin 17 Expression

Serum and Skin Levels of Mir-369-3p in Patients with Psoriasis and Their Correlation with Disease Severity

Mir-203 Contributes to IL-17-induced VEGF Secretion by Targeting SOCS3 in Keratinocytes

MicroRNA-31 overexpression may aggravate the formation of psoriasis-like lesions by STAT3/p53 pathway

MiR-155 Promotes Cell Proliferation and Inhibits Apoptosis by PTEN Signaling Pathway in the Psoriasis

Expression of CXCR3 Mrna in Lesions and Peripheral Blood Mononuclear Cell(pbmc)of Patients with Psoriasis Vulgaris

The Expression of Interleukin-22 and S100a7, A8, A9 Mrna in Patients with Psoriasis Vulgaris

Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis patients and their relation to IL-17

Mir-205-5p Inhibits Psoriasis-Associated Proliferation and Angiogenesis: Wnt/β-catenin and Mitogen-Activated Protein Kinase Signaling Pathway Are Involved.

Mirnas Flowing Up and Down: the Concerto of Psoriasis

Expression Of Tumor Necrosis Factor Alpha-Induced Protein 3 Mrna In Peripheral Blood Mononuclear Cells Negatively Correlates With Disease Severity In Psoriasis Vulgaris

MiR-150 Regulates Human Keratinocyte Proliferation in Hypoxic Conditions Through Targeting HIF-1α and VEGFA: Implications for Psoriasis Treatment.

The study of GSDMB in pathogenesis of psoriasis vulgaris

Expression of IGFBP3 and TNFSF15 mRNA in Dermal Mesenchymal Stem Cells of Patients with Psoriasis

MicroRNA-17-3p is upregulated in psoriasis and regulates keratinocyte hyperproliferation and pro-inflammatory cytokine secretion by targeting CTR9

Expression of Pro-Angiogenic Genes in Mesenchymal Stem Cells Derived from Dermis of Patients with Psoriasis

Expressions of CK20, S100A7 and Substance P in Different Stages of Psoriatic Lesions and Their Relationship.

miR-320b Is Down-Regulated in Psoriasis and Modulates Keratinocyte Proliferation by Targeting AKT3

MiR‐126 correlates with increased disease severity and promotes keratinocytes proliferation and inflammation while suppresses cells' apoptosis in psoriasis

The Expression of Interleukin-23 （p19/p40） and Inteleukin-12 （p35/p40） in Psoriasis Skin